Kelly Elise Dooley

Associate Professor

20022018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 29 Similar Profiles
rifapentine Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
bedaquiline Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

Schalkwijk, S., Ter Heine, R., Colbers, A. C., Huitema, A. D. R., Denti, P., Dooley, K. E., Capparelli, E., Best, B. M., Cressey, T. R., Greupink, R., Russel, F. G. M., Mirochnick, M. & Burger, D. M., Mar 8 2018, (Accepted/In press) In : Clinical Pharmacokinetics. p. 1-13 13 p.

Research output: Contribution to journalArticle

efavirenz
Pregnant Women
Pharmacokinetics
Pregnancy
Population

Challenges of TB and HIV co-treatment: updates and insights

Tornheim, J. & Dooley, K. E., Nov 1 2018, In : Current opinion in HIV and AIDS. 13, 6, p. 486-491 6 p.

Research output: Contribution to journalArticle

Tuberculosis
HIV
Multidrug-Resistant Tuberculosis
Therapeutics
Routine Diagnostic Tests

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Alfarisi, O., Mave, V., Gaikwad, S., Sahasrabudhe, T., Ramachandran, G., Kumar, H., Gupte, N., Kulkarni, V., Deshmukh, S., Atre, S., Raskar, S., Lokhande, R., Barthwal, M., Kakrani, A., Chon, S., Gupta, A., Golub, J. E. & Dooley, K. E., Nov 1 2018, In : Antimicrobial agents and chemotherapy. 62, 11

Research output: Contribution to journalArticle

Pyrazinamide
Diabetes Mellitus
Tuberculosis
Pharmacokinetics
Isoniazid

High-dose rifampin: Shall we be bolder?

Dooley, K. E., Sep 1 2018, In : American journal of respiratory and critical care medicine. 198, 5, p. 558-560 3 p.

Research output: Contribution to journalEditorial

Rifampin

Levofloxacin population pharmacokinetics in south african children treated for multidrug-resistant tuberculosis

Denti, P., Garcia-Prats, A. J., Draper, H. R., Wiesner, L., Winckler, J., Thee, S., Dooley, K. E., Savic, R. M., McIlleron, H. M., Simon Schaaf, H. & Hesseling, A. C., Feb 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 2, e01521-17.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Levofloxacin
Pharmacokinetics
Weights and Measures
Population